source
- MassBio CEO warns 2025 may be biotech's toughest year amid China and NIH challengesMassachusetts is widely regarded as the epicenter of biotech because of its world‑class research institutions and vibrant startup ecosystem. MassBio CEO Kendalle Burlin O’Connell said 2025 will pr…
- Flagship’s ProFound Therapeutics secures up to $35 M from Gates Foundation to discover preeclampsia drug targetsFlagship Pioneering’s ProFound Therapeutics has entered a new partnership with the Gates Foundation that could provide up to $35 million for research. The agreement includes an initial $20 million…